Latest thrombocytopenic purpura Stories

2014-12-04 23:06:58

Market Size - $381.99 million in 2013, Market Growth - CAGR of 5.9%, Market Trends - Growing usage rates of combination therapy - New report published by Grand View Research.

2011-01-26 08:29:41

Thrombotic thrombocytopenic purpura (TTP) is a potentially-fatal blood disorder that causes blood clots to form in small blood vessels that affect many organs including the liver, kidneys, heart, pancreas, and brain.

2011-01-25 13:14:29

Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease of the blood system.

2008-11-03 18:00:20

Protalex, Inc. (OTCBB:PRTX) today announced that Steven H. Kane, President and Chief Executive Officer, will present at the upcoming Rodman & Renshaw 10th Annual Healthcare Conference on Monday, November 10, 2008 at 3:40 p.m. Eastern Time.

2008-08-25 12:01:19

Amgen has announced that the FDA has approved Nplate, the first and only platelet producer for the treatment of thrombocytopenia in splenectomized and non-splenectomized adults with chronic immune thrombocytopenic purpura.

2008-07-17 12:01:18

Symphogen and Biovitrum have announced the recruitment of the first patient into a Phase II clinical trial, initiated in June 2008 to evaluate the safety and efficacy, and explore the dose range of Sym001 in idiopathic thrombocytopenic purpura patients.

2008-06-20 18:00:39


2008-06-16 09:01:17

Amgen has announced new positive data from the ongoing, open-label extension study on the long-term safety and efficacy of romiplostim in adult patients with chronic immune thrombocytopenic purpura, a chronic and serious autoimmune disorder characterized by low platelet counts in the blood.

Word of the Day
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.